Page last updated: 2024-08-23

lonidamine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

lonidamine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Costantini, P; Goulbern, M; Hirsch, F; Kroemer, G; Marzo, I; Miccoli, L; Petit, PX; Poupon, MF; Ravagnan, L; Reed, JC; Susin, SA; Xie, Z; Zamzami, N	1

Other Studies

1 other study(ies) available for lonidamine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

Article	Year
Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene, 1999, Apr-22, Volume: 18, Issue:16 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Cell-Free System; Cysteine Proteinase Inhibitors; Humans; Indazoles; Ion Channels; Isoquinolines; Mitochondria; Permeability; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Subcellular Fractions; U937 Cells	1999

Article

Year

Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore.

Oncogene, 1999, Apr-22, Volume: 18, Issue:16

Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Cell-Free System; Cysteine Proteinase Inhibitors; Humans; Indazoles; Ion Channels; Isoquinolines; Mitochondria; Permeability; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Subcellular Fractions; U937 Cells

1999